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Abstract 
Natural killer (NK) cells are cytotoxic lymphocytes that selectively respond against 
abnormal cells.  Human cytomegalovirus (HCMV) infection causes expansion of 
NKG2C+CD57+ NK cells in vivo and NKG2C+ NK cells proliferate when cultured with 
HCMV-infected cells.  This raises the possibility of an NK-cell subset selectively 
responding against a specific pathogen and accruing memory.  To test this possibility, we 
compared proliferation, natural cytotoxicity and interferon- (IFN-) production of NK 
cells from HCMV-seropositive and HCMV-seronegative individuals co-cultured with 
HCMV-infected or uninfected MRC-5 cells.  There was no significant difference in 
proliferation of NK cells from HCMV-seropositive or seronegative individuals against 
uninfected MRC-5 cells, but significantly more NK cells from the HCMV-seropositive 
groups proliferated in response to HCMV-infected MRC-5 cells.  Natural cytotoxicity of 
NK cells against K562 cells increased following co-culture with HCMV-infected versus 
uninfected MRC-5 cells only for the HCMV-seropositive group.  After co-culture with 
HCMV-infected MRC-5 cells, proliferating NK cells from HCMV-seropositive donors 
selectively produced IFN- when re-exposed to HCMV-infected MRC-5 cells.  Both 
NKG2C+ and NKG2C- NK cells proliferated in co-culture with HCMV-infected MRC-5 
cells, with the fraction of proliferating NKG2C+ NK cells directly correlating with the 
circulating NKG2C+ fraction.  These data illustrate an at least partly NKG2C-independent 
human NK-cell memory-type response against HCMV.
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Chapter 1: Introduction 
1.1 Natural Killer Cells 
Natural Killer cells (NK cells) are bone-marrow derived granular lymphocytes 
comprising 5-25% of peripheral blood mononuclear cells (PBMC). NK cells are sentinels 
of the innate immune system that provide rapid protection against virally infected and 
neoplastic cells, controlling their dissemination through cytotoxic and proinflamatory 
cytokine responses without prior sensitization [2]. The importance of NK cells is most 
clearly established in viral infection as illustrated in individuals with NK cell deficiencies, 
who have elevated susceptibility to herpes infections and their conferred morbidities [3-6]. 
Initially, NK cells were believed to be a homogeneous cell population working in concert 
with cytotoxic T-cells by recognizing and lysing cells with aberrant major 
histocompatibility complex class I (MHC-I) expression. Advances in NK cell biology have 
since revealed their heterogeneous nature in both function and phenotype, including 
specialized populations with immunoregulatory roles as well as long lived NK cells with 
immunological memory [7, 8].   
Host protection from virus infection and cancer is achieved through several 
essential NK cell effector functions. First, NK cells produce an array of chemokines and 
cytokines that conduct host immune responses through chemotaxis and activation of other 
immune cells. This function endows NK cells with the ability to tune up or dampen 
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impending and ongoing immune responses, as illustrated by their promotion of type 1 
CD4+ T-cell priming, and conversely, by their capacity to kill activated dendritic cells [9, 
10]. Interferon gamma (IFN) represents the prototypical NK cell cytokine, which is 
released upon NK cell activation [11]. This multifaceted messenger protein is essential in 
the early stages of infection for its induction of MHC-I on antigen presenting cells (APCs), 
activation of phagocytes to control obligate intracellular pathogens, as well as directly 
inhibiting viral replication and proliferation of malignant transformed cells [12-14]. NK 
cells also provide host protection through cytotoxic intervention using perforin and 
granzyme B sequestered within cytoplasmic granules. Upon interaction with a target cell, 
NK cells form an immunological synapse and release their stored perforin, which 
oligomerizes to form pores in the target cells membrane. These perforin channels disrupt 
the osmotic polarity of the cell membrane resulting in cell lysis, or serve as portals for the 
passive diffusion of granzyme B, which initiates apoptosis of the target cell [15].  
Unlike B and T cells, NK cells lack the recombination machinery necessary for 
generation of clonal antigen receptors, and, therefore, are believed to lack antigen 
specificity. Instead, NK cell control is mediated through a sophisticated arsenal of germline 
encoded inhibitory and activating receptors that ligate receptors expressed on healthy and 
aberrant cells [16, 17]. Inhibitory NK cell receptors are characterized by the presence of 
immunoreceptor tyrosine-based inhibitory motifs (ITIMs) within their long cytoplasmic 
tails, that when engaged, recruit phosphatases that act to dampen the cell’s state of 
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activation [18, 19]. In contrast, activating receptors generally have short cytoplasmic tails 
free of ITIM’s, but have a positively charged amino acid, namely arginine or lysine, within 
their transmembrane region. When phosphorylated, these residues act as docking sites for 
signaling adaptor molecules bearing immunoreceptor tyrosine-based activating motifs 
(ITAM’s) such as DAP10 and DAP12, which initiate cascades involved in activation [18, 
19]. NK cell activation is determined by an integration of these signals upon interaction 
with a target cell, acting as an excitatory rheostat for appropriate initiation of effector 
functions. 
Major histocompatibility complex (MHC) class 1 proteins act as ligands for many 
inhibitory NK cell receptors. This receptor ligand interaction acts as a failsafe against NK 
cell mediated-autoimmunity toward healthy tissues, as MHC class I molecules are 
ubiquitously expressed on the surface of nucleated cells. However, when MHC class I 
expression declines, such as in viral infection and cancer, the inhibitory threshold is 
reduced, thereby increasing the likelihood of NK cell detection and killing [20-24]. In this 
model, activating receptors also recognize ubiquitously expressed proteins on the cell 
surface, but inhibitory signals act as the determinants of the response. NK cell recognition 
in the context of aberrant MHC class I expression is termed “missing self” detection (figure 
1)[19, 25]. This contrasts with “induced self” detection where activating receptors dictate 
effector function by recognizing ligands expressed on stressed cells (figure 1a-c)[26-28]. 
Although these models differ, it is important to note that they are not mutually exclusive. 
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 Figure 1.0: Mechanisms of NK cell target detection and self-tolerance. NK cells are 
tolerant of healthy cells, as the strength of excitatory input is dampened by inhibitory NK 
cell receptor engagements with self MHC-I (a). When host cells become stressed, such as 
in viral and bacterial infection or caner, NK cell activating receptors recognize induced 
ligands on the cell surface resulting in a net positive signal and subsequent NK cell attack 
(b). Viral infection and cancer often downregulate MHC-I to evade detection by cytotoxic 
T-cells. NK cells can be activated by these cells because they are no longer kept in check 
by inhibitory receptor engagement with self-MHC-I (c). 
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Besides recognition of stress induced ligands and loss of MHC-I, NK cells can be 
activated by antibody opsonized targets. Appropriately coined antibody dependent cell-
mediated cytotoxicity (ADCC), NK cells span the gap between innate and adaptive 
immunity with the ability to recognize antibodies bound to targets through the low affinity 
Fc receptors FcRIIIa and FcRIIc (CD16) [29, 30]. Like other excitatory NK cell 
receptors, CD16 lacks intracellular activating motifs and instead relies on ITAM 
containing adaptor proteins, namely CD3ζ or FcεRIγ [31, 32]. Upon ligation with 
antibodies, CD16 becomes co-localized with either of these two adaptor proteins which 
then initiates potent excitatory signaling cascades that end in cytokine production and 
cytotoxic granule release [31, 32]. It is important to note that NK cell-mediated ADCC 
cannot be triggered by low threshold antibody stimulation, but requires crosslinking of 
multiple CD16 molecules to overcome basal NK cell inhibitory signaling [33]. 
Crosslinking and the low affinity of the receptor likely provide failsafe against 
inappropriate NK cell activation that may otherwise occur due to ubiquity of antibodies in 
vivo.  
1.2 NK cell Education and Tolerance 
NK cell functional development relies on interactions between NK cell inhibitory 
receptors and MHC class I expressed on bone marrow stromal cells [34]. These interactions 
define the basal inhibitory threshold of each NK cell and ensure self-tolerance [35]. This 
process of “NK cell education”, is indispensable due to the stochastic nature of NK cell 
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receptor acquisition, which gives rise to thousands of functionally different NK cell subsets 
[35, 36]. 
A selective process in NK cell maturation involving inhibitory NK receptors was 
first suggested with the observation that all NK cells collected from two unrelated donors 
expressed at least one inhibitory receptor for self MHC class I  [37]. NK cell subsets void 
of self-MHC class I specific inhibitory receptors have since been observed [38, 39], 
however, these cells are not self-reactive, are generally unresponsive to excitatory receptor 
engagement in vitro, and fail to target MHC class I deficient targets [34, 38, 40]. Similar 
observations have been made in studies using NK cells carrying inhibitory receptors with 
mutated ITIM motifs, which conserve inhibitory receptor interactions with MHC class I, 
but interrupt downstream inhibitory signaling. When introduced during development, such 
mutations render NK cells hyporeactive, but paradoxically, inhibitory receptor blockade in 
mature NK cells enhances responsive potential [40]. Together, these data strongly suggest 
inhibitory NK cell receptor interactions with self MHC-I augment NK cell responsiveness 
and ensure self-tolerance. However, the molecular mechanism governing NK cell 
education is largely unknown. 
While poorly understood, three hypotheses exist that address the mechanism of NK 
cell education and self-tolerance: the “licensing model”; the “disarming model”; the 
“rheostat model” (figure 1.1). The licensing model postulates that NK cells are initially 
unresponsive, but become “licensed” to function following inhibitory receptor engagement 
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with self MHC-I (figure 1.1a)[40]. In support of this model, transgenic mice that have 
complete expression of foreign MHC-I develop NK cells that reject self-bone marrow and 
lymphocytes. This autoreactivity is proposed to be facilitated by NK cells lacking 
inhibitory receptors for self MHC-I, but express those that recognize the introduced 
protein, resulting in inappropriate licensing and a subsequent breech in NK cell self-
tolerance [41]. This finding suggests that NK inhibitory receptor interactions may play an 
instructive role, rather than inhibitory, in NK cell education. It is important to note that 
“self” bone marrow was only rejected in this study following ex vivo culture, and therefore 
results may reflect an artifact of experimental design, rather than NK cell licensing [41].  
 In contrast to the licensing model, the disarming model suggests that NK cells are 
initially responsive, but when left uninhibited are rendered anergic by chronic stimulation 
from normal cells (figure 1.1b)[42]. This model of NK cell education is supported by 
studies using transgenic mice with mosaic expression of non-self MHC-I. Such mice 
express the foreign protein on a fraction of their hematopoietic cells, but curiously fail to 
reject self-bone marrow like those with complete expression [41]. This finding indicates 
that effective NK cell education requires ubiquitous expression of self MHC-I, supporting 
an inhibitory role of these interactions as predicted by the disarming model [34, 41, 43]. 
However, SHIP-1 phosphatases, which are important in NK cell inhibitory signaling, are 
seemingly dispensable for NK cell education questioning the role of inhibitory interactions, 
and thus the disarming model [44].  
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Alternatively, the rheostat hypothesis theorizes that NK cell responsive potential is 
bestowed quantitatively and differentially based on the frequency and affinity of inhibitory 
receptor engagements during development (figure 1.1c)[43, 45]. In support of this theory, 
NK cells bearing multiple inhibitory receptors for self MHC class I respond more 
frequently and elicit stronger effector functions than those bearing a single self-inhibitory 
receptor [46]. Further studies have found that NK cell education is also influenced by the 
affinity of these inhibitory interactions, with stronger binding leading to heightened 
responsiveness [47]. Evidently, it seems NK cell responsive potential may be bestowed on 
a continuum where NK cells can be “tuned up” to counter chronic inhibitory stimulation 
from self, or “tuned down” when self-inhibition is weak. This process likely fine tunes 
immature NK cells to their optimal responsive potential, while simultaneously insuring 
self-tolerance [45].  
Although each model is independently supported, it is important to note these 
hypotheses are not mutually exclusive, and NK cell education is likely achieved by 
combination of these mechanisms. Additionally, recent evidence suggests that NK cells 
education may not be permanently endowed during NK cell development, but rather reflect 
a dynamic process. For instance, multiple recent studies have found that mature NK cells 
can be educationally “re-programmed” following exposure to novel HLA environments 
[48, 49].   
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Figure 1.1: Hypothesized mechanisms of NK cell education. The licensing model postulates 
that NK cells are initially unresponsive, but become “licensed” to function following inhibitory 
receptor engagement with self MHC-I (a). In the disarming model, NK cells are initially 
responsive, but when left uninhibited are rendered anergic by chronic stimulation from normal 
cells (b). The rheostat hypothesis theorizes that NK cell responsive potential is bestowed 
quantitatively and differentially based on the frequency and affinity of inhibitory receptor 
engagements during development (c) 
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1.3 NK cell Receptors 
1.3.1 Ly49 Receptors 
The highly-studied c-type lectin-like Ly49 proteins represent a large NK cell 
receptor family in mice. These proteins have both inhibitory and activating isoforms which 
respectively signal through ITIMs in their cytoplasmic tail, or ITAM-containing adaptor 
proteins [50, 51]. Inhibitory isoforms generally ligate with murine MHC class I proteins, 
while activating isoform ligands remain mostly unidentified [52]. However, some 
excitatory Ly49 have been shown to bind MHC-I in the presence of viral chaperones, as 
well as MHC-I-like viral gene products [53-55]. Recognition of cognate H-2 requires the 
presence of a bound peptide within the groove of the MHC protein [56-58]. Although these 
interactions are peptide dependent, they are generally not peptide-specific, as crystal 
structures demonstrate that Ly49 receptor-binding residues are distal to the peptide-binding 
groove of MHC-I[59]. One exception is inhibitory Ly49C, which has been shown to 
provide differing protective capacities based on the peptide bound to its cognate H-2 ligand 
[60].  
As consequence of binding MHC-I, one of the most highly polymorphic loci in 
mammals, Ly49 receptors have evolved into an extensively polymorphic receptor system 
[61]. The close proximity of Ly49 gene loci results in inheritance of variable haplotypes, 
often including receptors for MHC-I alleles absent in a given animal [19]. Adding to this 
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complexity, the Ly49 repertoire seems to be initially stochastically generated giving rise 
to variegated expression patterns between strains and between individual NK cells [62-
64].  However, the functional repertoire seems to be shaped by MHC-I dependent 
educational processes which silence potentially autoreactive clones and disfavor those with 
multiple self-specific Ly49 receptors [65]. In a separate process, the density of Ly49 
proteins on NK cells is altered to an optimal amount based on the level of MHC-I 
expression in the animal [66, 67]. This mechanism is believed to occur 
posttranscriptionally through ligand mediated downmodulation [62]. 
1.3.2 Killer-cell immunoglobulin-like receptors (KIR) 
In primates the Ly49 family of receptors is absent except for a single residual 
pseudogene within the Ly49 gene cluster in humans [68]. However, these proteins seem to 
have been replaced by the structurally distinct killer immunoglobulin-like receptors (KIR) 
through an exquisite example of convergent evolution [69]. Supporting this theory are 
striking similarities between the two protein families, including the presence of inhibitory 
and excitatory isoforms with common ITIM and ITAM signaling. Additionally, both 
inhibitory KIR and Ly49 proteins recognize MHC-1 proteins and are involved in NK cell 
education, while activating isoforms bind ligands indicative of host cell aberration [69]. 
Evolution of both gene sets has also taken remarkably similar routes including multiple 
duplication episodes and common descent of excitatory isoforms from inhibitory 
counterparts [70]. 
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Although functionally and evolutionarily similar, KIR are structurally distinct from 
Ly49 receptors as type 1 glycoproteins of the immunoglobulin superfamily. As this 
suggests, KIR share structural features with immunoglobulins in the form of two to three 
immunoglobulin folds [71]. These domains are extracellular and denoted in KIR 
nomenclature as KIR2D or KIR3D. Alleles are further characterized by possession of long 
or short cytoplasmic tails as denoted in their classification as an L(long) or an S(short), 
which proceeds the number of extracellular domains (eg. KIR2DL or KIR2DS). Long 
cytoplasmic tails  are the product of ITIM motifs and characterize inhibitory KIR, while 
excitatory forms are short and rely on ITAM containing adaptor proteins [72]. KIR 
specifically bind HLA-A, -B, and -C, and have been shown to interact with the peptide 
binding region of these proteins when a peptide is bound [73-75]. Evidently, KIR 
demonstrate peptide selectivity by recognizing broad amino acid motifs, which contrasts 
with T-cell receptors, which recognize specific epitopes [76].  
Like Ly49, KIR are highly polymorphic and polygenic with 14 to 17 receptors and 
hundreds of distinct alleles [77]. KIR repertoires are inherited as two differing haplotypes 
termed group A and group B. Group A haplotypes show little variation in gene content 
between individuals and are dominated by inhibitory receptors, while group B haplotypes 
are highly variable and contain multiple stimulatory KIR. Receptors within haplotype A 
provide high affinity recognition of MHC-I molecules, and those within group B contribute 
diversity to the NK cell repertoire [78]. Interestingly, group B haplotypes have been 
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associated with elevated protection in several diseases including cancer and human 
immunodeficiency virus (HIV) infection, illustrating their importance in host defense [79-
83]. Expression of KIR is initially stochastic producing subsets of NK cells with variable, 
but overlapping KIR phenotypes. The initial KIR repertoire is then condensed through 
educational processes to generate a functional NK cell pool. This expression system creates 
an arsenal of unique NK cells and increases recognition of a broad array of target cells [39, 
84].  
1.3.3 NKG2 Receptors 
Another important group of receptors in NK cell function are the highly conserved 
NKG2 proteins. This family of transmembrane receptors structurally belong to the c-type 
lectin-like superfamily and consists of seven members: NKG2A; B; C; D; E; F; H 
[85].  Isotypes exist as inhibitory or excitatory forms in an analogous manner to KIR and 
Ly49 and have an integral role in NK cell cytotoxic responses [86]. Of these, five species 
(NKG2A, B, C, E and H) have been shown to form disulfide linked heterodimers with 
CD94, which has a short cytoplasmic region involved in signal transduction [87]. Dimeric 
CD94/NKG2 recognizes the widely distributed, but scantily expressed non-classical 
MHC-I protein HLA-E. HLA-E serves the specialized role of presenting leader peptide 
sequences trimmed from classical MHC-I during their expression. Therefore, NKG2 
proteins allow for NK cells to examine the health of cells by indirectly detecting aberrations 
in classical MHC-I expression [85, 88]. 
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1.4 Adaptive Characteristics of NK cells  
Immunological memory refers to the immune system’s ability to mount responses 
of greater magnitude and with faster kinetics upon reencounter with the same antigen. This 
immune attribute conventionally defines responses mediated by T and B cells, which carry 
somatically recombined antigen receptors and that following priming, generate long lived, 
phenotypically distinct memory cells with enhanced function [89]. In contrast, NK cells 
favor a binary mode of activation governed by a finite number of germline encoded 
receptors that recognize a restricted panel of ligands expressed on healthy and stressed 
cells. Evidently, there is no commonly accepted mechanism to endow NK cells with the 
capacity for either selective adaptation to antigen exposure or for immunological memory 
[16, 17]. This concept, however, is becoming rapidly challenged by evidence of NK cell 
subpopulations with extended life spans and augmented recall responses. Current research 
has elucidated NK cell memory-like responses through three main forms of challenge: 
hapten based contact sensitization; cytokine induced memory; viral infection [90-92]. 
NK cell antigenic memory was first demonstrated by T and B-cell deficient mice 
exhibiting hapten-based contact hypersensitivities (CHS) [93]. CHS reactions are a form 
of delayed-type hypersensitivity (DTH) that occurs when the epithelial surface is exposed 
to compounds known as haptens. Haptens bind and chemically alter self-proteins allowing 
for their detection by the adaptive immune system and a subsequent development of 
hapten-specific memory cells. Upon reencounter with the same hapten the secondary 
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immune response presents as redness and swelling of the exposed area [94]. Considered a 
classic example of adaptive memory, it came as a surprise when Von Adrian et al. 
discovered such responses to 2,4-dinitrofluorobenzene and oxazolone in T and B-cell 
deficient mice. Incredibly, these responses were hapten specific, long lasting (>4 weeks), 
and conferred on naïve mice by adoptive transfer of hepatic NK cells from exposed mice 
[95]. Research from the same group also demonstrated NK mediated DTH responses to 
virus like particles (VLP) of human immunodeficiency virus, influenza and vesicular 
stomatitis virus [93]. Antibody blockade experiments revealed that DTH responses from 
both forms of challenge rely on expression of chemokine receptor CXCR6 on liver resident 
NK cells [96]. However, CXCR6 is also expressed on splenic and unsensitized hepatic NK 
cells, which fail to mount specific immune responses to haptens and VLPs [96]. The 
mechanism underlying NK cell mediated CHS responses in mice remains unsolved, but 
demands elucidation in hopes of similar discovery in humans. Translation of NK cell based 
DTH responses into human models would undoubtedly lead to advances in vaccination and 
adoptive NK cell therapies.  
In addition to CHS responses, NK cells gain memory-like features when 
preactivated with a cocktail of interleukin-12 (IL-12), IL-15 and IL-18. This phenomenon 
was first defined by Yokoyama and colleagues after adoptively transferring cytokine 
stimulated murine NK cells into T and B cell deficient syngeneic mice [97]. These 
preactivated NK cells were phenotypically identical to untreated NK cells, but persisted up 
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to three weeks later, and produced IFN at higher frequencies upon restimulation with 
cytokines or activating receptor engagement [97]. This ability to retain memory of past 
cytokine activation has also been demonstrated in human NK cells, which upon stimulation 
with IL-12, IL-15 and IL-18 develop similar enhancement [98, 99]. However, unlike mice, 
human CIML (cytokine-induced memory-like) NK cells display elevated cytotoxic 
potential, specifically against leukemia cell lines and human AML (acute myeloid 
leukemia) blasts in vitro [99]. These findings have since been translated into phase I 
clinical trials in which cytokine preactivated NK cells were adoptively transferred into 
patients combating AML. Therein, transplanted NK cells proliferated, exhibited 
heightened anti-leukemic function in vitro, and in four cases led to complete remission 
[100]. Despite their use in humans, the molecular mechanism governing memory-like 
attributes of these cells still requires elucidation.   
Although NK cells gain memory-like aspects following various forms of challenge, 
identification of NK cell subpopulations endowed with antigen specific receptors remain 
elusive and provocative, with one exception. Infection of mice with MCMV serves as the 
gold standard for NK cell virus interaction, representing the only definitive example of 
NK-mediated antigenic memory in any species. In C57BL/6 mice, circulating NK cells 
carry the activating C-type lectin Ly49H, which directly binds the MCMV virulence factor 
M157 expressed on infected cells [101-103]. Recognition of M157 drives an NK cell 
response strikingly like those mediated by T-cells with all hallmarks of adaptive immunity 
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including clonal expansion upon antigen recognition, contraction following clearance, and 
establishment of a memory population [104, 105]. Cells from the memory pool are 
detectable as late as 70 days post infection, and display enhanced effector function 
following secondary expansion ex vivo. Furthermore, these cells confer protection against 
MCMV re-challenge, but not from heterologous infections, defining them as bona-fide 
MCMV specific memory cells [106-108].  
Recognition of M157 by murine NK cells is achieved due to homologies between 
M157 and Ly49H’s native ligand H-2. Therefore, M157 likely functions as an MCMV 
evasion protein derived to attenuate the anti-MCMV NK cell response by binding 
inhibitory Ly49. However, this strategy was likely evolutionarily countered by the 
emergence of excitatory Ly49 isoforms that also recognize H-2 [103-106]. Underlining 
the importance of the M157 antigen in this response are experiments using mutant MCMV 
lacking M157, or variants recognized by inhibitory Ly49, which fail to preferentially 
expand Ly49H+ NK cells and protect mice from infection [106, 109]. Taken together, 
murine NK cells can remember previous exposure with a pathogen. However, proof of 
antigenic recognition and memory in human NK cells remains a challenge. 
In primates, NK cell-mediated adaptive responses have proved challenging to 
unmask, likely due to ethical and economic constraints attached to their experimentation. 
Nevertheless, headway on this topic has been made. For example, human NK cells have 
been shown to lyse influenza infected cells through the recognition of hemagglutinin (HA) 
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by the activating receptor NKp46 in a glycosylation dependent fashion [110-112].  In one 
independent study, healthy volunteers vaccinated with formulations of the seasonal 
influenza vaccine elicited augmented IFN production by NKp46+ NK cells upon viral 
restimulation for up to six months post vaccination [113]. This finding is evocative of NK 
cell antigenic memory in mice, however, clonal expansion and development of a discrete 
memory population is yet to be described. It is possible that the NK cell memory pool 
resides outside the peripheral blood compartment evading the scope of researchers. 
 Besides recognition of HA, one study has shown that human NK cells 
preferentially kill autologous B cells pulsed with peptides derived from Epstein Barr virus 
(EBV) and CMV, but only when collected from EBV and CMV exposed donors akin to 
adaptive memory [114]. While intriguing, the mechanism governing these peptide specific 
NK cell responses could not be determined and the results are yet to be replicated. 
However, comparable results have been shown in simian immunodeficiency virus (SIV) 
and simian-human immunodeficiency virus (SHIV) infected macaques [115]. Hepatic and 
splenic NK cells from infected animals rapidly eliminate gag and env-pulsed autologous 
dendritic cells in a NKG2-dependent fashion [112]. Of particular interest, macaques also 
develop NK cell memory responses following Ad26-vaccination, which can be elicited up 
to 5 years post vaccination [115]. These findings indicate that primate NK cells can elicit 
robust antigen specific memory responses following infection and vaccination.   
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Reminiscent of Ly49H+ NK cells in MCMV, human cytomegalovirus (HCMV) 
infection is associated with the durable expansion of an NK cell subpopulation found 
within the functionally mature CD56dim NK cell fraction [116]. These cells express high 
levels of the activating c-type lectin NKG2C, and express the terminal differentiation 
marker CD57, marking NKG2C+CD57+ NK cells as a mature population with distinct 
phenotype and function [116, 117]. NKG2C+CD57+ NK cells have been shown to expand 
in vivo during acute HCMV infection and during HCMV reactivation post solid organ and 
hematopoietic stem cell transplantation [118-121]. This response yields an NKG2C+ 
memory population that remains long term (>1 year) and when transplanted from 
seropositive donors elicits enhanced effector function upon secondary HCMV exposure 
[120, 122]. Curiously, these results are only seen in HCMV+ recipients with active or 
subclinical expression of HCMV antigens [120, 122]. Furthermore, HCMV infected 
fibroblasts have been shown to expand NKG2C+CD57+ NK cells in vitro, but only in 
HCMV seropositive donors [123]. Failure to generate NKG2C+CD57+ NK cells in 
seronegative donors in vitro illustrates an intrinsic difference between this system and 
NKG2C+ NK expansion in vivo. 
Although HCMV infection is clearly integral in the expansion of memory-like 
NKG2C+CD57+ NK, there is little evidence of the driving mechanism. In in vitro 
experiments NKG2C+CD57+ NK expansion following stimulation with HCMV-infected 
fibroblasts is abrogated by NKG2C blockade using monoclonal antibodies [123, 124]. This 
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implicates that this receptor helps mediate proliferation of memory-like NK cells, but the 
mechanistic significance of its presence remains unclear. One possibility lies in the NKG2 
ligand HLA-E, which presents leader peptides from classical MHC class I molecules to 
NK cells [88]. NK cells can be activated by subtle differences in HLA-E bound peptide, 
thus, it is conceivable that HCMV peptides may be recognized by NKG2C via HLA-E 
presentation to promote preferential expansion of NKG2C+ cells [125-127]. In support of 
this theory, certain HCMV derived peptides loaded on HLA-E promote degranulation of 
NK cells bearing NKG2C, provided its inhibitory counterpart NKG2A is absent [127, 128]. 
This finding is in-line with the phenotype of NKG2C+CD57+ NK cells, which lack co-
expression of NKG2A [117]. Alternatively, it is possible that NKG2C may be working 
akin to Ly49H in MCMV and directly recognizes an unknown viral protein expressed on 
the surface of infected cells.   
 While in vitro proliferation can be interpreted as a secondary response of NKG2C+ 
NK cells initially activated by HCMV in vivo, the mechanistic basis for selective expansion 
of this NK cell subset and adaptive memory is unclear. To further investigate the possibility 
that proliferation of NK cells from HCMV-seropositive subjects during co-culture with 
HCMV-infected fibroblasts represents immunological memory, we compared responses of 
NK cells from HCMV-seropositive and seronegative individuals to co-culture with 
HCMV-infected cells in the absence of exogenous cytokines. If memory NK cells are in 
fact generated during HCMV infection, NK cells from seropositive donors will deliver 
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more robust proliferative responses following exposure to HCMV-infected cells compared 
to those collected from seronegative donors. Additionally, enhanced proliferation should 
be coupled with augmented function, such as elevated cytotoxicity and selective cytokine 
production by responding cells, to fully recapitulate the classical elements of 
immunological memory. Therefore, following in vitro HCMV-expansion we investigated 
the phenotype and cytokine production of responding and non-responding cells, as well as 
changes in NK cell cytotoxic potential towards an MHC-I bare cell line.  Our data are 
consistent with an adaptive NK cell response to HCMV, but raise questions as to a primary 
role for NKG2C in this response. 
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Chapter 2: Materials and Methods 
2.1. Subjects and sample processing 
This study received ethical approval from the Newfoundland and Labrador Health 
Research Ethics Authority.  Whole blood was collected with informed consent from 
apparently healthy donors by forearm venipuncture into acid-citrate dextrose containing 
vacutainers.  Whole blood was initially centrifuged for 10 min at 1000g and plasma 
collected to determine HCMV serostatus.  The packed cellular whole blood fraction was 
then diluted with phosphate buffered saline (PBS) to twice its original volume and PBMC 
isolated by density gradient centrifugation using Ficoll hypaque (GE Healthcare 
Biosciences, Mississauga, ON, Canada).  T cells were depleted using EasySep CD3+ 
selection kits (STEMCELL Technologies Inc, Vancouver, BC, Canada) before co-culture 
with HCMV-infected cells.   
2.2. HCMV Lysate ELISA 
HCMV lysate was generated by infecting 1 x 107 human MRC-5 fibroblasts with 
AD169-HCMV at an MOI of 0.5 and harvested after 3 days of propagation. Infected cells 
were mechanically removed from the plate using a sterile scraper, pelleted via 
centrifugation and lysed in 1mL of lysis buffer. The lysate was then diluted 1/1000 in 
bicarbonate coating buffer, and 100L was added to each well of a Immunlon-2 ELISA 
plate (VWR Scientific, Mississauga, Ontario, Canada) and incubated overnight at 4°c. 
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Plasma samples were thawed, diluted 1/500 with PBS, and added to the lysate coated plate 
before a 90 minute incubation. In sequence, the plate was washed and developed with goat-
antihuman IgG-horseradish peroxidase conjugate (Jackson ImmunoResearch Labs, West 
Grove Pennsylvania, USA) followed by tetramethylbenzidine substrate (Sigma-Aldrich, 
St. Louis, Missouri, USA). Colour was developed for 30 minutes in the dark at room 
temperature, and stopped using 1N H2SO4. Optical density was read at 450nm using a 
BioTek Synergy HT fluorometer. HCMV positives were identified based on relative 
minimum fluorescence detection limit of diluted plasma from a clinically confirmed 
HCMV+ standard control. Negative control wells followed the same protocol, but the lysate 
was generated in the absence of AD169.  
2.3. NK co-culture with HCMV-infected MRC-5 cells 
MRC-5 cells were a kind gift from Dr. K. Hirasawa, Division of BioMedical 
Sciences, Faculty of Medicine, Memorial University of Newfoundland.  The HCMV lab 
strain AD169 was obtained through the NIH AIDS Reagent Program, AIDS Program, 
NIAID, and NIH from Dr. Karen Biron [129].  2.5 x 105 MRC-5 fibroblasts were seeded 
into 24 well plates, and grown in Dulbecco’s Modified Eagle’s Medium (DMEM) 
supplemented with 10% non-inactivated fetal calf serum (FCS), 100 g/mL streptomycin, 
100 IU/mL penicillin, 2 mM L-glutamine, and 1% sodium pyruvate (all from Invitrogen, 
Carlsbad, CA, USA).  Once confluent, MRC-5 cells were infected with the AD169 at 
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multiplicity of infection (MOI) 0.025 for 1 hour, or left untreated.  Cells were then 
incubated at 37°C in a 5% CO2 humidified incubator and monitored daily for development 
of cytopathic effects (3-4 days).  T-cell depleted PBMC from HCMV-seropositive and 
seronegative donors (3.0 x 106) were stained with 5 µM CFSE as per manufacturer’s 
(Invitrogen, Carlsbad, CA, USA) protocol and placed into culture with HCMV-infected, 
or uninfected, MRC-5 cells (figure 2.0a).  Cells were then co-cultured for 14 days in 
RPMI-1640 supplemented with 10% FCS, 100 g/mL streptomycin, 100 IU/mL 
penicillin, 2 mM L-glutamine, 10 mM HEPES buffer, and 2 x 10−5 M 2-mercaptoethanol 
(all from Invitrogen, Carlsbad, CA, USA).  Medium was partially replaced each 2-3 days. 
Following co-culture proliferation was analyzed by flow cytometry using CFSE 
fluorescence intensity dilution (figure 2.0b). To assess production of IFN- by cultured 
proliferating and non-proliferating NK from HCMV-seropositive individuals, cells were 
cultured as described and on day 14, transferred to 24 well plates containing MRC-5 cells 
newly infected with HCMV as described above.  After 1 hour, brefeldin A (Sigma-Aldrich, 
St. Louis, MO, USA) was added to 10 g/mL.  The cells were kept in co-culture a further 
4 hours and IFN- production by proliferating and non-proliferating NK measured by 
intracellular flow cytometry (figure 2.0c).   
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2.4. Antibodies and Flow Cytometry  
The proportion of NKG2C+ CD57+ NK in subjects’ circulating PBMC was 
measured by flow cytometry using the following fluorochrome-conjugated monoclonal 
antibodies: anti-CD3-peridinyll chlorophyll protein (PerCP), clone BW264/56 (Miltenyi, 
San Diego, CA, USA;); anti-CD56-fluorescein isothiocyanate (FITC), clone MEM188 
(eBioscience, San Diego, CA, USA); anti-CD57-phycoerythrin (PE), clone HNK-1 
(Biolegend, San Diego, CA, USA); anti-NKG2C-allophycocyanin (APC), clone 134591 
(R&D Systems, Minneapolis, MN, USA).  PBMC were washed twice in flow cytometry 
buffer (0.2% sodium azide, 0.5% FCS, 5 mM EDTA in PBS), stained, washed again and 
fixed with 1% paraformaldehyde in PBS.  To measure proliferation of NKG2C+ and 
NKG2C- NK cells following co culture with HCMV-infected MRC-5 cells, co-cultured 
cells were washed twice with flow cytometry buffer and stained with anti-CD3-PerCP, 
anti-CD56-PE, anti-NKG2C-APC and eFluor 780 (eBioscience) viability marker.  Viable 
lymphocytes were identified, CD3+ cells excluded and CD56+ cells gated for analysis.  
Proliferation of NKG2C+ and NKG2C- CD56+ was assessed by CFSE dilution.  Anti-IFN-
 APC (clone 4S.B3) from eBioscience was used to analyze IFN--producing cells.  Data 
were analyzed using Kaluza software (Beckman Coulter, Brea, CA, USA). 
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2.5. NK Cytotoxicity Assay  
The co-culture procedure for cytotoxicity assays was as described above without 
CFSE staining. Changes in NK cytotoxicity following HCMV co-culture were assessed 
against K562 target cells.  K562 were labeled with 100 µCi Na251CrO4 (MP Biomedicals, 
Santa Ana, CA, USA) for 90 minutes at 37°C.  Cells were removed from co-culture with 
HCMV-infected and uninfected cells, numbers normalized and maximizing the use of 
recovered cells, tested in duplicate at high, medium and low effector to target (E:T) ratios 
against 5 x 103 K562 target cells in a total volume of 300 µL RPMI-1640 supplemented as 
above.  Maximum release wells contained K562 cells in 1 N HCl, while minimum release 
wells contained K562 cells in medium alone. The plate was incubated at 37°C for 5 hours 
in a 5% CO2 humidity controlled incubator and radioactivity released into supernatants 
measured using a Wallac Wizard 1470 gamma counter.  Percent specific lysis was 
calculated as test 51Cr release – spontaneous 51Cr release/maximum 51Cr release – 
spontaneous 51Cr release x 100. 
 
2.6. Statistical Analysis 
All statistical analysis was performed using Graphpad Prism software, version 
5.01. All data sets were first assessed for normality by Kolmogorov-Smirnov test.  
Differences between the responses of HCMV-seropositive and seronegative groups and 
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between the percentages of CFSEhi and CFSElo NK cells producing IFN- in response to 
HCMV-infected cells were assessed by non-parametric two-tailed Mann-Whitney testing.  
The Wilcoxon signed rank test for paired samples was used to test the significance of 
increased NK cytotoxicity following co-culture with HCMV-infected cells.  Correlations 
were assessed using Spearman’s Rank Correlation Coefficient.  P values < 0.05 were 
considered significant.   
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Figure 2.0. HCMV co-culture to assess HCMV specific NK cells. T-cell depleted PBMC 
from HCMV-seropositive and negative donors are stained with CFSE and co-cultured with 
HCMV infected MRC-5 for 14 days (A). Proliferation of CD3-CD56+ NKG2C+ and 
NKG2C- cells is then assessed by CFSE fluorescence intensity dilution (B), and co-
cultured cells transferred to a secondary culture of HCMV infected MRC-5 for five hours 
to assess IFNy production by proliferated and non-proliferated NK cells (C). All cultures 
are run in duplicate and in parallel with uninfected co-cultures as a control. 
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Chapter 3: Results 
HCMV infection has been strongly linked in independent studies to the expansion 
and maintenance of NKG2C+CD57+ NK cells, which expand in response to HCMV 
reactivation, and exhibit increased activity following a secondary HCMV event. These 
observations are reminiscent of HCMV specific NK responses seen in mice, but there is 
no evidence for specific recall. To elucidate HCMV specific NK memory we compared 
NK expansion, phenotype, and function between HCMV seropositive and seronegative 
donors following in vitro stimulation with HCMV infected fibroblasts.  
 
3.1. Selective proliferation of NK cells from HCMV-seropositive donors. 
To test whether HCMV infection in vivo sensitizes NK cells to respond to HCMV-
infected cells in vitro, we co-cultured freshly-isolated NK cells from 19 HCMV-
seropositive and 11 seronegative individuals with uninfected or HCMV-infected MRC-5 
fibroblasts and measured NK cell proliferation over 14 days.  Proliferation of CD3-CD56+ 
NKG2C+ and NKG2C- cells was assessed on day 14 of culture by carboxyfluorescein 
succinimidyl ester (CFSE) fluorescence intensity dilution as shown (Figure 3.1.0). 
Representative flow plots collected from a HCMV-seropositive and seronegative donor are 
shown in figure 3.1.1 and figure 3.1.2, respectively. Proliferation of NK cells cultured with 
uninfected MRC-5 cells ranged from 0.8% to 26.3%, with no significant difference 
between HCMV-seropositive and seronegative donors; mean % proliferating NK = 10.90, 
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95% confidence interval (95% C.I.) 5.77-16.03 versus 7.88, 95% C.I. 4.90-10.85, p = 0.25 
(Figure 3.1.4). In response to HCMV co-culture NK cell proliferation ranged from 1.67% 
to 48.32% in HCMV-seropositive donors, and 0.91% to 19.54% in the seronegative group. 
Curiously, only cells collected from HCMV-seropositive donors consistently elicited 
greater NK cell proliferative responses towards HCMV-infected MRC-5 compared to the 
control. Conversely, responses from HCMV-seronegative donors were often greater when 
co-cultured with uninfected MRC-5 (Figure 3.1.3), likely due to viral cytolysis and a 
temporal decrease in stimulation. After subtracting NK cell proliferation in response to co-
culture with uninfected MRC-5 fibroblasts, we observed significantly more proliferation 
of NK cells from HCMV-seropositive donors; median % proliferating NK = 7.70, 
interquartile range (IQR) 6.23-20.82 versus 0.80, IQR 0.00-4.60, p < 0.0001(Figure 
3.1.5). These data suggest that host infection with HCMV sensitizes NK cells to proliferate 
in vitro when exposed to HCMV-infected cells.         
Due to the use of magnetic separation for the depletion of T-cells in our system, 
which has a maximum effective removal of 99%, few cultures contained small numbers of 
contaminating T-cells. To account for the possibility of these T-cells affecting NK cell 
proliferation we correlated the relative proportion of CD3+ cells post HCMV co-culture 
with total NK cell proliferation. We found no significant relationship between the 
proportions of contaminating T-cells and HCMV-induced NK cell proliferation; r=-0.29, 
p > 0.05 (figure 3.1.6). 
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Figure 3.1.0  Gating strategy to assess NK-cell proliferation in response to HCMV-
infected MRC-5 cells.  Proliferation of CD3-CD56+ NKG2C+ and NKG2C- cells was 
assessed by CFSE fluorescence intensity dilution following 14 day HCMV-co-culture 
without exogenous cytokines.  Representative flow cytometry plots from left to right above 
show dead cell exclusion, lymphocyte inclusion, gating on CD56+CD3- cells and 
representation of proliferating NKG2C+ and NKG2C- cells. 
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Figure 3.1.1 NK cell proliferation of an HCMV-seronegative donor in response to 
HCMV-infected MRC-5. Following 14 day co-culture, proliferation of CD3-CD56+ 
NKG2C+ and NKG2C- NK cells was assessed. Proliferated CFSElow NK cells in the 
uninfected (left) and HCMV-infected (right) co-cultures are highlighted within the black 
squares, and annotated numbers represent relative proportions of proliferating NK cells.  
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Figure 3.1.2 NK cell proliferation of an HCMV-seropositive donor in response to 
HCMV-infected MRC-5.  Following 14 days co-culture, proliferation of CD3-CD56+ 
NKG2C+ and NKG2C- cells was assessed. CFSElow NK cells proliferated in uninfected 
(left) and infected (right) co-cultures are highlighted within the black squares, and 
annotated numbers represent relative proportions of proliferating NK cells. 
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Figure 3.1.3 HCMV-seronegative donor preferentially expanding against uninfected 
MRC-5.  After 14 days co-culture, proliferation of CD3-CD56+ NKG2C+ and NKG2C- 
cells is assessed by CFSE fluorescence intensity dilution. Proliferated CFSElow NK cells in 
the uninfected (left) and infected (right) co-cultures are highlighted within the black 
squares, and annotated numbers represent relative proportions of proliferating NK cells.  
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Figure 3.1.4  NK-cell proliferation in response to MRC-5 cells. Proliferation of NK cells 
from 19 different HCMV-seropositive (right) and 11 seronegative individuals (left) in 
response to co-culture with healthy MRC-5 cells.  Horizontal lines bisecting the groups 
represent mean values for the groups with 95% confidence intervals shown above and 
below (mean % proliferating NK = 10.90, 95% C.I. = 5.77-16.03 versus 7.88, 95% C.I. 
4.90-10.85). Significance between means are shown above bars spanning the groups 
compared (p = 0.25) (Students t-test).  Data are pooled from 5 experiments with 3 to 5 
donor samples per experiment.       
36 
 
 
 
Figure 3.1.5  NK-cell proliferation in response to HCMV-infected MRC-5 cells.  
Proliferation of NK cells from 19 different HCMV-seropositive and 11 seronegative 
individuals in response to co-culture with uninfected MRC-5 cells was subtracted for each 
donor to derive net specific NK cell proliferation against HCMV infected MRC-5 cells. 
Horizontal lines bisecting the groups represent median values for the groups with 
interquartile range shown above and below compared (median % proliferating NK = 7.70, 
IQR 6.23-20.82 versus 0.80, IQR 0.00-4.60). Significant differences between medians are 
shown above bars spanning the groups (p = 0.0002) (Mann–Whitney test). Data are pooled 
from five experiments with three to five donor samples per experiment. 
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Figure 3.1.6 Effect of contaminating T-cells on NK cell expansion following HCMV-
co-culture.  Following 14 day HCMV co-culture, HCMV-seropositive donor cultures were 
quantified for contaminating fractions of CD3+ cells. Relative proportions of T-cells were 
then correlated with relative proportions of expanding NK cells by spearman correlation to 
determine potential effect of HCMV-specific T-cells on NK cell expansion ( r = -0.286, p 
= 0.501).  
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3.2 Selective functional enhancement of NK cells from HCMV-seropositive donors.  
Adaptive immunity involves the selective expansion of antigen-specific cell 
populations with concurrent acquisition of enhanced effector functions.  To determine 
whether the selective proliferation of NK cells from HCMV-seropositive individuals co-
cultured with HCMV-infected fibroblasts was reflected in enhanced function, non CFSE-
labeled NK cell co-cultures were set up in parallel for 7 HCMV-seropositive and 7 
seronegative individuals and direct cytotoxicity against K562 target cells was measured on 
day 14 of co-culture.  Differences in cytotoxicity between NK cells cultured with 
uninfected versus HCMV-infected fibroblasts were somewhat variable, with lysis of K562 
cells by NK cells from the majority of HCMV-seronegative individuals falling, by up to 
27%.  However, for two donors, K562 lysis increased by 9 and 27% respectively (Figure 
3.2.0).   
In aggregate, there was no statistically significant change in killing of K562 cells 
for the HCMV-seronegative group following co-culture with HCMV-infected fibroblasts 
versus co-culture with uninfected fibroblasts; p > 0.05 (Wilcoxon signed rank test) (Figure 
3.2.0).  In contrast, NK cells from HCMV-seropositive donors consistently increased their 
cytotoxicity against K562 cells following co-culture with HCMV-infected fibroblasts 
versus co-culture with uninfected fibroblasts (Figure 3.2.1).  In 6 of 7 individuals tested, 
NK cell cytotoxicity increased by 4-46%, with NK cells from one donor showing a 9% 
decrease in cytotoxicity (Figure 3.2.1).  Overall, killing of K562 by NK cells from HCMV-
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seropositive individuals following co-culture with HCMV-infected cells was significantly 
increased over killing by NK cells co-cultured with uninfected cells; p < 0.046 (Figure 
3.2.1).  These data suggest that host infection with HCMV sensitizes NK cells to acquire 
enhanced cytotoxic function when exposed to HCMV-infected cells in vitro.  Thus, NK 
cells from HCMV-infected individuals selectively demonstrate attributes of memory 
lymphocytes when exposed to HCMV-infected cells in vitro and tested for cytotoxic 
function.  
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Figure 3.2.0  Effect of HCMV co-culture on natural cytotoxicity in HCMV-
seronegative donors.  Co-cultured cells from 7 HCMV-seronegative were collected, 
counted and tested at equal E:T ratios for killing of K562 cells after 14 days co-culture 
with either HCMV-infected or uninfected MRC-5 cells.  Lines joining percent specific 
lysis values show the direction of change in cytotoxicity for each individual following co-
culture with HCMV-infected (right column) or uninfected MRC-5 cells (left column).  The 
significant difference in percent lysis between co-culture with uninfected versus HCMV-
infected MRC-5 for the HCMV-seronegative donors is shown above the bar spanning the 
group values (p = 0.0813) (Wilcoxon signed rank test). 
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Figure 3.2.1  Effect of HCMV co-culture on natural cytotoxicity in HCMV-
seropositive donors.  Co-cultured NK cells from 7 HCMV-seropositive individuals were 
collected, counted and tested at equal E:T ratios for killing of K562 cells after 14 days co-
culture with either HCMV-infected or uninfected MRC-5 cells.  Lines joining percent 
specific lysis values show the direction of change in cytotoxicity for each individual 
following co-culture with HCMV-infected or uninfected MRC-5 cells.  The significant 
difference in percent lysis between co-culture with uninfected versus HCMV-infected 
MRC-5 for the HCMV-seropositive donors is shown above the bar spanning the group 
values (p = 0.047) (Wilcoxon signed rank test). 
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3.3 NK cells proliferating in vitro in response to HCMV-infected MRC-5 selectively 
recognize HCMV-infected cells 
To test whether NK cells proliferating in vitro in response to HCMV-infected 
MRC-5 cells selectively recognized HCMV-infected cells compared to the non-
proliferating NK cells, we re-exposed NK cells co-cultured with HCMV-infected MRC-5 
cells for 14 days to freshly infected HCMV-infected cells for 5 hours.  Production of 
interferon-gamma (IFN-) was compared between NK cells that had undergone 
proliferation and those that had not proliferated (Figure. 3.3.0).  In 8/8 cases tested, we 
observed selective IFN- production by NK cells that had undergone proliferation in 
response to in vitro exposure to HCMV-infected MRC-5 cells.  A representative example 
is shown (Figure 3.3.1).  Overall, a significantly higher fraction of the NK cells that had 
undergone proliferation produced IFN- when re-exposed to HCMV-infected MRC-5 cells 
(median % proliferating NK cells producing IFN- = 17.74, IQR 10.95-35.74 versus 3.30, 
IQR 1.86-4.81, p = 0.0002) (Mann-Whitney test).  For 6 HCMV-seropositive individuals 
tested, no NK cells produced IFN- when freshly-isolated. 
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Figure 3.3.0  Effect of re-exposure to HCMV-infected MRC-5 cells on proliferated 
NK-cell IFN- production. Cells from 8 HCMV-seropositive individuals were collected 
after 14 days HCMV co-culture and transferred to freshly infected MRC-5 cells for 5 
hours, after which IFN- production by proliferating (CFSElo) and non-proliferating 
(CFSEhi) NK cells was assessed.  Horizontal lines bisecting the groups represent median 
values for the groups with interquartile range shown above and below (median % 
proliferating NK cells producing IFN- = 17.74, IQR 10.95-35.74 versus 3.30, IQR 1.86-
4.81).  Significant differences between medians are shown above bars spanning the groups 
compared (Mann-Whitney test) (p = 0.0002). 
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Figure 3.3.1 IFN- production by proliferating and non-proliferating NK cells 
following re-exposure to HCMV-infected cells. Cells from HCMV-seropositive 
individuals were collected after HCMV co-culture and re-exposed to freshly infected 
MRC-5 cells, after which IFN- production by proliferating (CFSElo) and non-
proliferating (CFSEhi) NK cells was assessed. General gating strategy was as described in 
figure 1A with the addition of anti-IFN-. Relative percentages of gated cells are annotated 
within each quadrant of the plot. 
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3.4 NKG2C+ and NKG2C- NK proliferate in response to HCMV-infected fibroblasts 
in vitro.   
Since previous reports of NK cell proliferation in response to HCMV-infected cells 
in vitro focused on NKG2C+ NK cells from HCMV-seropositive donors, we measured the 
fraction of proliferating NK cells from HCMV-infected donors that expressed NKG2C in 
our system.  In 14 HCMV-seropositive subjects tested, the percentage of proliferating NK 
cells expressing NKG2C ranged from 0-83% (Figure 3.4.0). With two exceptions, the 
majority of NK cells proliferating in response to HCMV-infected cells did not express 
NKG2C in our in vitro system. An anecdotal example of an HCMV-seropositive donor 
eliciting little NKG2C+ proliferation is depicted in figure 3.4.1, and an example with most 
responding cells expressing NKG2C in figure 3.4.2.   
As the individual with the highest fraction of proliferating NK cells expressing 
NKG2C also had the highest fraction of circulating NK cells expressing NKG2C, we 
evaluated the correlation between circulating and proliferating NK cell fractions expressing 
NKG2C.  Figure 3.4.3 shows the significant correlation observed, r = 0.67, p = 0.009 
(Spearman’s rank correlation co-efficient).  This indicates that expansion of NKG2C+ NK 
cells in response to HCMV-infected cells in vitro occurs proportionately to the size of the 
starting NKG2C+ NK cell population.  There was no significant correlation between the 
fraction of circulating NK cells expressing NKG2C and the total percentage of NK cells 
proliferating in vitro in response to HCMV-infected cells.  Together, these data suggest 
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that despite the in vivo accumulation of CD57+NKG2C+ NK cells associated with HCMV 
infection, NKG2C is not necessary for selective in vitro proliferation of NK cells from 
HCMV-seropositive subjects in response to HCMV-infected cells.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
47 
 
 
 
Figure 3.4.0 Effect of HCMV co-culture on the proliferation of NKG2C+ NK cells. 
NK cells from HCMV-seropositive donors were harvested from 14-day HCMV-co-culture, 
and proliferation of CD3-CD56+ NKG2C+ cells was assessed by flow cytometry. Depicted 
are the relative fractions of proliferating NKG2C+ NK cells for 14 HCMV-seropositive 
subjects with a horizontal bar bisecting the group representing the median and interquartile 
range shown above and below (Median 21.7, IQR 11.79-38.82). 
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Figure 3.4.1 Preferential expansion of NKG2C- NK cells in response to HCMV 
infected MRC-5. Proliferation of CD3-CD56+ NKG2C+ cells was assessed following 14 
day HCMV-co-culture. Depicted above is a representative example showing HCMV-
seropositive individual with low (12%) proportions of NKG2C+ cells among NK cells 
proliferating in response to HCMV-infected MRC-5 cells. 
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Figure 3.4.2 Preferential expansion of NKG2C+ NK cells in response to HCMV 
infected MRC-5. Proliferation of CD3-CD56+ NKG2C+ cells was assessed following 14 
day HCMV-co-culture. Depicted above is an example showing a donor with high (83%) 
proportions of NKG2C+ cells among NK cells proliferating in response to HCMV-infected 
MRC-5 cells. 
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Figure 3.4.3  Correlation between fractions of NKG2C+ NK cells in peripheral blood 
and in NK cells proliferating in response to HCMV-infected cells. NK cells from 
HCMV-seropositive donors were harvested from 14-day HCMV-co-culture, and 
proliferation of CD3-CD56+ NKG2C+ cells was assessed by flow cytometry. Relative 
proportion of proliferating NKG2C+ NK cells was correlated with relative in vivo fractions 
of NKG2C+ NK cells measured prior to co-culture. The correlation coefficient (r) and 
probability of significant correlation (Spearman’s rank correlation co-efficient) are shown 
within the plot frame. 
51 
 
Chapter 4: Discussion 
4.1 Research summary 
By comparing the selective proliferation of NK cells from HCMV-seropositive 
versus seronegative individuals in response to HCMV-infected or uninfected fibroblasts, 
we found evidence of a memory-type NK cell response against HCMV-infected cells.  A 
significantly higher percentage of NK cells from HCMV-seropositive subjects proliferated 
against HCMV-infected cells and NK cells from HCMV-seropositive subjects were 
significantly more likely to increase their cytotoxicity against K562 target cells following 
co-culture with HCMV-infected cells.  In addition, a significantly greater fraction of the 
NK proliferating than non-proliferating in response to HCMV-infected cells in vitro 
produced IFN- when re-exposed to HCMV-infected cells.  These features characterize 
classical secondary immune responses detected in vitro following in vivo priming of the 
immune system through infection, vaccination or other forms of antigenic exposure.  While 
our findings are consistent with previous observations of selective expansion of an 
NKG2C+ NK cell subset in individuals infected with HCMV, the in vitro proliferative 
response against HCMV-infected cells we observed was predominantly independent of 
NKG2C expression.  The in vivo selective expansion of NKG2C+ NK cells in HCMV-
infected individuals is paralleled in the in vitro expansion systems used by several groups 
showing that this subset does proliferate in response to HCMV-infected cells and responds 
robustly against HCMV-infected cells via antibody-dependent cytokine responses in vitro 
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[123, 130].  Since the NKG2C subset rarely expands to substantial levels in HCMV-
seronegative individuals, it was not feasible to compare proliferation of NKG2C+ NK cells 
from HCMV-seronegative subjects in response to HCMV-infected cells in vitro.  
However, we did not observe a significant correlation between the overall extent of NK 
cell proliferation against HCMV-infected cells and the percentage of circulating NK cells 
expressing NKG2C in HCMV-seropositive responders.  Despite the clearly selective 
expansion of NKG2C+ NK cells associated with HCMV infection in vivo, our in vitro 
system, which recapitulated the classical elements of immune memory, indicates that NK 
cells can respond robustly against HCMV-infected cells independently of NKG2C 
expression.   
4.2 Comparison with the literature  
Our findings do not necessarily conflict with previous studies focused on the 
NKG2C+ NK cell subset, but likely reflect application of different in vitro co-culture 
conditions and choice of subjects.  We depleted T cells and added no exogenous cytokines 
to co-cultures, which potentially limits NK cell expansion.  Several previous studies 
described marked increases in NKG2C+ NK cells, to the point where they outnumbered the 
NKG2C- NK cell population by day 10-12 of co-culture [123, 124]. This rarely occurred 
in our system, possibly due to the lack of exogenous interleukin (IL)-2, as expansion of 
NKG2C+CD57+ NK has been linked to monocyte produced IL- 
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Figure 4.0 NK cell resposes of HCMV-seropositive donors following HCMV co-culture. After 
14 day exposure to HCMV infected MRC-5 fibroblasts, NK cells from HCMV-seropositive donors 
selectively expand and elicit elevated cytotoxicity against MHC-I deficient targets. In addition, 
significantly greater fractions of proliferated NK produce IFN- when re-exposed to HCMV-
infected cells compared to bystander NK. These features characterise classical secondary immune 
responses, but are recapitulated by NK cells using our system. 
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12, which sensitizes NKG2C+CD57+ NK cells to IL-2 by inducing CD25 expression [124]. 
This phenomenon paired with HLA-E engagement on infected cells by NKG2C without 
its inhibitory counterpart NKG2A, a hallmark of this NK cell population, may selectively 
expand NKG2C+CD57+ NK cells in vitro [131]. In this respect, previous studies have 
found that HLA-E expression on infected fibroblasts contributed to NKG2C+CD57+ NK 
expansion in vitro [123, 124].  While antibody blockade of NKG2C or its HLA-E ligand 
reduced NK cell proliferation in vitro, the molecular basis for specific NKG2C/HLA-E 
interactions contributing to the NK cell response against HCMV infection remains 
unspecified [123, 124].   
The NKG2 ligand, HLA-E, presents leader peptides from classical MHC class I 
molecules to NK cells [132, 133].  Subtle differences in HLA-E bound peptides can lead 
to NK cell activation, thus, it is conceivable that HCMV peptides are recognized by 
NKG2C via HLA-E presentation, thereby promoting preferential expansion of NKG2C+ 
cells [125, 126, 134, 135].  Certain HCMV derived peptides loaded on HLA-E do promote 
degranulation of NK cells bearing NKG2C, in the absence of its inhibitory counterpart 
NKG2A, consistent with the predominant phenotype of functionally mature 
NKG2C+CD57+ NK cells [116, 117, 127, 136].  The cytokine environment and possibly 
the HLA-E/NKG2C stimulatory axis may be subdued in our in vitro system compared to 
others.  In addition, our subjects were mostly young to middle-aged healthy adults with 
relatively low frequencies of NKG2C+ NK cells.  Most cases of pronounced NKG2C+ NK 
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cell expansion in vivo occur against a backdrop of genetic, infectious or transplant-related 
immunodeficiency [118, 120, 137, 138].  Selection of NK cells for in vitro culture from 
individuals with high circulating frequencies of CD57+NKG2C+ NK cells, whether 
acquired acutely or through protracted processes, may skew results to represent a terminal 
rather than evolving process of NK cell adaptation to HCMV, similar to the accumulation 
of terminally differentiated CD28-CD57+ CD8+ T cells specific for HCMV in old elderly 
and human immunodeficiency virus-infected subjects [138, 139].  In this context, the 
subject with the highest NKG2C+ NK cell response in our system was the oldest individual 
in our study and also had the highest circulating NKG2C+ NK cell frequency.   
The scarcity of robust NKG2C responses in our systems conforms with previous 
studies, which reported robust NKG2C+CD57+ proliferation in only half of donors tested 
[123, 124]. Variable responses between HCMV-seropositive donors may be explained by 
the distribution of differentially expressed killer-cell immunoglobulin-like receptors (KIR) 
on human NK cells. Inhibitory KIR are highly polymorphic and stochastically expressed, 
which generates many NK subsets with differing inhibitory thresholds that likely affect 
subset expansion in our system. With regards to NKG2C+CD57+ NK, there is evidence 
that this subset expresses inhibitory KIR for self MHC-I, which may lower inhibitory 
signaling when MHC-I alleles expressed on MRC-5 differ from the host [117]. 
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Perhaps the strongest evidence for an NKG2C-independent component or stage in 
the NK cell response to HCMV is HCMV infection-associated maturation of NK cells from 
NKG2Cnull individuals.  Adaptive cells in the NK cell populations of HCMV-infected 
individuals have been defined by exclusive or additive loss of FcεR, SYK kinase and 
Ewing’s sarcoma’s/FLI1-activated transcript 2 (EAT-2) adaptor proteins, or the 
transcription factor promyelocytic leukaemia zinc finger protein (PLZF) [140, 141].  
Absence of these proteins actually signifies NK cell acquisition of adaptive qualities such 
as superior proliferation upon engagement of intracellular tyrosine activation motif 
(ITAM) coupled receptors and enhanced cytokine responses [140-142].  There is 
significant overlap between the population of CD57+NKG2C+ and NK cells lacking these 
proteins, as illustrated in figure 4.1, which may relate to their robust in vivo and in vitro 
expansion in certain subjects with elevated fractions [140]. Individuals lacking a functional 
NKG2C gene undergo HCMV driven NK cell maturation, illustrated by analogous 
expansion of CD57+NKG2A- NK cells and the aforementioned HCMV-associated 
adaptive NK cells [143, 144].  Conversely, one study did find HCMV-related NK 
maturation to be delayed in NKG2Cnull children and there is evidence of NK cell 
compensation for NKG2C deficiency by up-regulation of CD2 [145, 146].  Thus, even if 
NKG2C is at least partially dispensable for the NK cell response to HCMV infection, it 
appears to confer a selective advantage reflected by in vivo and in vitro enrichment for 
NKG2C+ NK cells.       
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Figure 4.1 Overlap of NK cell fractions with HCMV driven protein deficiencies. 
HCMV has been shown to drive additive or exclusive loss of the adaptor proteins FcεR, 
SYK kinase, and EAT-2, as well as the transcription factor PLZF. Such deficiencies are 
associated with the acquisition of adaptive qualities in NK cells, and have significant 
overlap with the CD57+NKG2C+ NK cell population. This may relate to the durable 
expansion of NKG2C+ NK cells in persons with HCMV. Figure adapted from 
“Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with 
altered signaling and effector function”, Schlum et al.[137].     
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4.3 Research limitations 
  Despite careful attention to detail and planning during the execution of this study,  
there are, as with all studies, some limitations that dampen the ability to draw firm 
conclusions regarding NK cell adaptive responses using our system. Firstly, we used 
magnetic separation for T-cell depletion, a cost effective and efficient method of bulk 
removal. However, the maximum effective depletion lies just below 100%, therefore T-
cell contamination can be unavoidable without further intervention. This presents the 
possibility of HCMV-specific T-cells from seropositive donors affecting NK cell 
proliferation and function through the cytokine responses in vitro. Reducing the 
seriousness of this issue, few cultures contained detectable levels of T-cell contamination, 
and the proportions of T-cells in cultures that did had no measurable effect on NK cell 
proliferation as illustrated by figure 3.6.  Nonetheless, this issue should not be disregarded, 
and requires further experimentation to draw firm conclusions regarding these adaptive NK 
cell responses.  
 A second limitation stems from the use of the HCMV lab strain AD169, which has 
been extensively passaged, and consequently has suffered substantial deletions throughout 
its genome. This includes a 15kb deletion containing 19 open reading frames within 
HCMV’s long unique region (UL/b′) otherwise present in clinical isolates [147, 148]. 
Absence of these genes allow AD169 to be permissive in human fibroblasts cell lines, but 
retards replication in endothelial and epithelial cells, the primary sites of replication in vivo 
[149, 150]. These genes are essential for the persistence of HCMV in the host, and as a 
result AD169 does not replicate in vivo, even in individuals undergoing 
immunosuppressant therapy [151-154]. Evidently, some researchers question the validity 
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of AD169 as a model virus for HCMV. While this could be problematic when studying the 
characteristics of HCMV, our work is geared toward elucidation of adaptive NK cell 
responses using AD169 as a tool. However, the genetic abnormalities of AD169 may relate 
to the limited NKG2C+ NK cell responses in vitro. It is conceivable that these cells may 
recognize a viral ligand expressed by clinical strains of HCMV, but deleted from the highly 
passaged AD169. 
 Another potential limitation stems from the potential confounding variable of 
education/HLA background of the NK cell donors. It is important to note that preferential 
expansion of NK cells from specific donors could be altered based on their individual KIR 
phenotypes by lacking inhibitory receptors or possessing activating receptors for HLA 
expressed or downregulated on HCMV-infected MRC-5. Evidently, to fully interpret and 
analyze our findings it would be important to asses donor KIR profiles and the expression 
of HLA and other KIR ligands on MRC-5 cells with and without infection. 
4.4 Future Directions 
 Future directions for this research should center around understanding the 
underlying mechanism of these adaptive NK cell responses. For example, are these 
memory like responses driven by an HCMV induced ligand, or by recognition of a viral 
antigen by a currently undefined NK cell receptor, or perhaps by simple selection process. 
Uncovering such mechanisms would redefine NK cells as an immune cell, and would 
undoubtedly present opportunity for exploitation in vaccine development and treatment of 
cancer.  
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 While we found variable responses from NKG2C+ NK cells, this population 
provides some selective advantage as reflected by in vivo and in vitro enrichment. 
Therefore, defining the precise phenotype of these cells and comparing them with those 
eliciting memory-like responses using our system may be useful in identifying receptors 
involved. However, fractions of NKG2C+CD57+ NK cells are generally very small in 
healthy individuals, thus acquiring a reliable sample size for accurate flow cytometry is 
difficult. To circumvent this issue, we would look to donors coinfected with HIV and 
HCMV, as such donors have exaggerated fractions of NKG2C+CD57+ NK cells, 
sometimes dominating 75% of the NK cell compartment. This anomaly is presumably a 
compensatory mechanism to control HCMV infection in the setting of compromised 
adaptive immunity [138]. 
 Because KIR profiles are implicated in antiviral NK cell responses, and this is the 
closest receptor family to Ly49 in mice, initial phenotyping should focus on this system. 
The first step in this process would be to define donors with the largest NKG2C+CD57+ 
NK cell fractions by flow cytometry. Once these individuals are selected, each donor would 
be genotyped for their specific KIR profile using commercially available PCR based typing 
kits. Using this information, individual fluor panels using anti-KIR antibodies would be 
tailored to each donor, and their NK cells analyzed by flow cytometry.  These data would 
then be used to determine trends in KIR related to HCMV induced expansion of 
NKG2C+CD57+ NK cells, which could then be compared to the responding cells in our 
system. Additionally, because KIR are involved in NK cell education further genotyping 
of donor MHC-I loci, the putative ligand of KIR, could be used to determine the 
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educational state of these cells. This may be useful considering uneducated NK cells have 
been found more effective at viral clearance of MCMV in mice [44]. 
A second future direction would be to address the limitations regarding the use of 
AD169 as a model virus of HCMV. This would be accomplished by repeating co-cultures 
using a clinical strain of HCMV such as Toledo, FIX, PH, or TR, which have been passaged 
to a limited extent in the laboratory and therefore have complete HCMV genomes [148]. 
However, clinical strains are notoriously difficult to grow in vitro due to limited replication 
in fibroblasts, and limited cytopathic effect. If these viruses prove unproductive it would 
be possible to control for the deleted UL/b′ region in AD169 by using fresh isolates of the 
HCMV strain Merlin. While Merlin is a laboratory strain like HCMV, the viral DNA was 
promptly inserted into a bacterial artificial chromosome (BAC) upon its clinical isolation. 
Evidently, Merlin can be stably cloned in e. coli and transfected to produce low passage 
virus with little genetic variation from wild-type HCMV, including an intact UL/b′ region 
[155]. 
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4.5 Concluding Remarks 
Selectively augmented proliferation, cytotoxicity and IFN- production by NK 
cells from HCMV-seropositive donors in response to HCMV-infected cells in vitro are 
hallmarks of a secondary immune response.  Despite the pronounced expansion of 
NKG2C+ NK cells in association with HCMV infection in vivo and in response to HCMV-
infected cells in other in vitro systems, we observed predominantly NKG2C-independent 
NK cell responses in vitro.  This, coupled with studies of NKG2Cnull individuals, suggests 
that selective NK cell responses against HCMV can be mounted independently of NKG2C, 
but evolve under extreme conditions or over protracted periods towards NKG2C+ 
dominance. 
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